Henkel has acquired US advanced materials start-up NBD Nanotechnologies for an undisclosed sum. Headquartered in Boston, Massachusetts, NBD specializes in developing coatings and additives with surface wettability.
US specialty chemicals company Stepan has agreed to acquire the surfactant business and associated assets of compatriot firm PerformanX Specialty Chemicals. The purchase will include intellectual property, commercial relationships and inventory.
French industrial gases group Air Liquide has announced the sale of its industrial merchant business in Saudi Arabia to Abdullah Hashim Industrial Gases & Equipment for an undisclosed sum.
Kemira has agreed to sell its colorants dye business to Chromascape, a US-based specialty colorants and additives supplier.
Indian specialty chemicals company Calibre Chemicals has agreed to acquire RheinPerChemie (RPC) from Evonik. Based in Rheinfelden, Germany, RPC manufactures ammonium and sodium persulfates.
IMCD has taken over Japanese specialty distribution company Kuni Chemical for an undisclosed sum. Kuni specializes in industrial applications that range from coatings and construction to automotive and packaging materials.
An affiliate of funds advised by SK Capital Partners has completed the sale of NuCera Solutions to international specialty chemicals company Chase Corp. for $250 million. The companies entered into the agreement on Jul. 18.
French engineering and technology company Technip Energies has boosted its sustainable chemicals portfolio with the purchase of DSM’s biosuccinium technology. Financial terms were not disclosed.
Clariant has agreed to sell its quats business to Singapore’s Global Amines for $113 million. Global Amines is a 50:50 joint venture between Clariant and Singapore-based agricultural and oleochemicals company Wilmar.
Danish pharma Novo Nordisk has agreed to acquire US clinical-stage biopharma Forma Therapeutics in a deal worth $1.1 billion that will expand its blood disorders portfolio. Forma’s board of directors has unanimously approved the takeover, which is expected to close in the final quarter of 2022.
Germany’s LTS Lohmann Therapie-Systeme has completed the acquisition of St. Paul, Minnesota-headquartered CDMO Tapemark, a US specialist in transdermal drug delivery systems, oral thin films and unit dose semi-solid drug and iontophoresis products.
German CDMO Evotec is to acquire compatriot company Central Glass Germany from Japanese owner Central Glass for a nominal price of €1. The transaction, which remains subject to the usual closing conditions, is expected to complete on Nov. 1.
Ineos Phenol is paying $330 million to acquire Mitsui Phenols Singapore. With the deal, expected to close in the first quarter of 2023, subject to regulatory approval, it will add 1 million tonnes of annual capacity to its production volume. The business had sales of $750 million in 2021 and 120 employees, all of whom will transfer to the new owner.
European private equity group Investindustrial — through subsidiary PVC Europe — has agreed a sale of PVC compounder Benvic to International Chemical Investors Group (ICIG). However, it expects to retain Benvic’s medical activities in Italy.
Novartis has finally confirmed definite plans to spin off its generic drugs arm Sandoz.
IMCD has agreed to buy PromaPlast, a distributor of advanced materials serving markets in Mexico and the US. Terms of the transaction, which is expected to close in September, were not disclosed.
Azelis has agreed to buy Turkish specialty chemicals distributor Dağalti Kauçuk San, marking its third acquisition in the country so far this year.
US specialty chemicals company Solenis has entered into an agreement to buy Clearon, a compatriot manufacturer of sanitizers and disinfectants for water treatment and household, industrial and institutional applications. Financial terms of the deal were not disclosed.
German engineering plastics producer Covestro has signed a definitive agreement to sell its Additive Manufacturing Business to US 3D printing specialist Stratasys for about €43 million. Closing of the deal is expected for the first quarter of 2023.
Göttingen, Germany-based life science group Sartorius, through its French-listed subgroup Sartorius Stedim Biotech, plans to acquire all shares of Nottingham, England’s Albumedix, a specialist in recombinant albumin-based solutions, for about £415 million.
Borealis has confirmed its intention to launch a squeeze-out offer for Belgian fertilizer producer Rosier. It already held 77.5% of Rosier and raised its shareholding to 98.09% through a capital increase late last month.
CDMO heavyweight Catalent is acquiring compatriot Metrics Contract Services, a full-service specialty CDMO with a facility in Greenville, North Carolina, for $475 million. Mayne Pharma Group is the seller.
Gilead Sciences has agreed to acquire MiroBio, a privately held UK biotech focused on treating inflammatory diseases, for about $405 million in cash.
Amgen is beefing up its inflammatory diseases portfolio with an agreement to buy US biopharma ChemoCentryx for roughly $3.7 billion. The deal gives Amgen access to vasculitis treatment Tavneos.
Pfizer is paying $5.4 billion to acquire Global Blood Therapeutics (GBT), a drugmaker specialized in treating blood disorders. It is one of several deals the company has inked recently to offset dwindling sales from its vaccine and therapeutics for Covid-19.
The consolidation in the distribution sector continues. In the latest deal, Life Sciences distributor Barentz International has announced the acquisition of Volp Indústria e Comércio, a Brazilian distributor of supplies and solutions for the Personal Care sector.
Univar Solutions has bought Vicom Distribución Productos Quimicos, a specialty chemicals distributor operating in Spain and Portugal, in its first acquisition of the year.
Australian biopharma CSL said this week it has received all the regulatory clearance required to take over Switzerland’s Vifor. The acquisition announced in December 2021 temporarily stalled in May 2022.
Trinseo has suspended plans for the sale of its styrenics business because of the current macroeconomic and geopolitical uncertainty. The company announced last November that it had begun exploring a potential divestment of the business, formally launching a sales process in the first quarter of this year.
Canadian fertilizer producer Nutrien has agreed to buy Brazil’s Casa do Adubo, boosting its growth in both Brazil and the Latin American region. Financial terms were not revealed.
French specialty chemicals producer Arkema has announced it will acquire privately owned Mexican company Polimeros Especiales, a producer of high performance waterborne resins for applications in architectural and decorative paints, textiles, pressure sensitive adhesives and construction.
Azelis is acquiring Chemical Solutions (ChemSol), a distributor of raw materials for the personal care, cosmetics and household market segments in Malaysia.
US-based Vertex Pharmaceuticals has agreed to pay $320 million in cash to acquire ViaCyte, a compatriot private cellular therapy company specializing in a treatment for type-1 diabetes (T1D). The transaction is expected to close later this year.
Solvias, a Swiss CDMO serving the pharmaceutical, biotechnology, material science and cosmetic industries, has acquired Dutch biotech Cergentis for an undisclosed sum. The deal bolsters Solvias’ platform of biologics and cell and gene therapy (CGT) testing solutions.
Brazilian oil group Petrobras has finalized the sale of its entire 27.88% stake in linear alkyl benzene (LAB) producer Deten Quimica to Spanish energy and petrochemicals group CEPSA Quimica for 514 million Brazilian reais.
